Table 4.
Clinical outcomes
| Variable | All patients | Vessel diameters ≤2.50 mm | Vessel diameters >2.5 mm | p value small versus large vessel diameters |
|---|---|---|---|---|
| Number of patients | 783 | 205 (26.2 %) | 578 (73.8 %) | – |
| Patients with clinical follow-up | 735 (93.9 %) | 191 (93.2 %) | 544 (94.1 %) | 0.627 |
| Follow-up time (months) | 9.5 ± 2.4 | 9.4 ± 2.1 | 9.6 ± 2.5 | 0.427 |
| Time to discharge (days) | 4.0 ± 12.8 | 6.0 ± 23.7 | 3.3 ± 4.7 | 0.014 |
| In hospital MACE | 30 (4.1 %) | 10 (5.2 %) | 20 (3.7 %) | 0.349 |
| In hospital TLR | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | – |
| In hospital MI | 17 (2.3 %) | 4 (2.1 %) | 13 (2.4 %) | 0.815 |
| In hospital cardiac death | 13 (1.8 %) | 6 (3.1 %) | 7 (1.3 %) | 0.094 |
| 9-month MACE | 75 (10.2 %) | 25 (13.1 %) | 50 (9.2 %) | 0.126 |
| 9-month TLR (Re-PCI, CABG) | 32 (4.4 %) | 12 (6.3 %) | 20 (3.7 %) | 0.129 |
| 9-month CABG | 5 (0.7 %) | 1 (0.5 %) | 4 (0.7 %) | 0.759 |
| 9-month MI | 38 (5.2 %) | 11 (5.8 %) | 27 (5.0 %) | 0.669 |
| 9-month cardiac death | 21 (2.9 %) | 8 (4.2 %) | 13 (2.4 %) | 0.199 |
| 9-month stroke rate | 3 (0.4 %) | 1 (0.5 %) | 2 (0.3 %) | 0.771 |
| 9-month total definite/probable stent thrombosis | 11 (1.4 %) | 5 (2.6 %) | 6 (1.1 %) | 0.138 |
| Acute stent thrombosis, ≤24 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | – |
| Subacute stent thrombosis,1-30 d | 1 (0.1 %) | 0 (0.0 %) | 1 (0.2 %) | 0.553 |
| Late stent thrombosis, ≥30 d | 10 (1.3 %) | 5 (2.6 %) | 5 (0.9 %) | 0.081 |